James Bibb, Ph.D., and colleagues have described a novel preclinical drug that could have the potential to combat depression, brain injury and diseases that impair cognition. The drug, which notably is brain-permeable, acts to inhibit the kinase enzyme Cdk5.
Researchers have developed a brain-permeable compound (25-106) that targets a signaling regulator in brain neurons. The team notes that when the new compound was administered to mice, it could alter their neurobehavior and reduce anxiety-like behavior.
Novel preclinical drug could have potential to combat depression, brain injury and cognitive disorders miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
nasa showed it really knows how to celebrate christmas by launching its most powerful space telescope ever. and liftoff. liftoff from tropical rainforest to the edge of time itself. james bibb begins a uh-uh uh-uh you voyage back to the universe. it involved thousands of scientists, multiple countries, and with some luck, may change the way we see the universe. it is going to take about a month to reach its destination about a million miles away. then several more months for the telescope to get set up. this astrophysicist adam frank